Edinburgh-based biotechnology firm, Calcivis, has secured £5m in funding to roll out its cutting-edge dental technology.

The firm's patented system enables early detection of tooth decay - which in turn can enable timely preventive treatment - by deploying a biologic diagnostic agent in combination with an imaging device. Calcivis aims to revolutionise early-intervention diagnostics in dentistry. Its innovative technology uses bioluminescence to highlight quickly and clearly where preventive measures are required before decay becomes irreversible.